MJUS: Big Implications As President Biden Reschedules Cannabis (NYSEARCA:MJUS)

dvulikaia The Amplify U.S. Alternative Harvest ETF (NYSEARCA:MJUS) saw increased activity on Thursday amidst the most significant piece of federal reform of cannabis recently, if not ever. President Biden has officially announced that the government will be moving to reschedule cannabis to Schedule III, with the Department of Justice filing their official notice. This comes…

Read More

What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner (VKTX)

marrio31 Shares of Viking Therapeutics (NASDAQ:VKTX) have surged in the last 12 months, driven by the success of its obesity candidate, the subcutaneously administered VK2735. VK2735’s efficacy, safety and tolerability data to date look very competitive, even when compared to the so-called triple G agonists such as Eli Lilly’s (LLY) retatrutide. And more recently, the…

Read More

VDC: Three Big Reasons To Go Defensive With This ETF (NYSEARCA:VDC)

eyecrave productions/E+ via Getty Images Investment Thesis Vanguard Consumer Staples ETF (NYSEARCA:VDC) is a buy due to multiple factors making the consumer staples sector attractive. These factors include high valuation indicators for the market overall including the “Buffett Indicator” and the overall price-to-earnings ratio of the S&P 500 Index. Additionally, while consumer staple funds, such…

Read More

Amazon Q1 Review: Best Of Big Tech Bunch (NASDAQ:AMZN)

Brett_Hondow/iStock Editorial via Getty Images Introduction In “Big Tech’s Big Breakdown, The Technical Setup Ahead Of Earnings,” I wrote the following about Amazon.com, Inc. (NASDAQ:AMZN): Along with Meta and Google, Amazon has been one of our largest holdings at TQI since its inception in late 2022. After being undervalued throughout 2022-23, Amazon’s stock has finally…

Read More

Immatics Stock: Big Pharma Partners, Intriguing Catalysts Make Buy Case (NASDAQ:IMTX)

luismmolina Investment Overview Immatics (NASDAQ:IMTX), based in Tuebingen, Germany, achieved its Nasdaq listing in 2020, via a business combination with Arya Sciences Acquisition Corp, a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors. According to Harvard Business Review: A SPAC is a publicly traded corporation with a two-year life span formed with the sole…

Read More

Big Monthly Dividends From Big Tech: JEPQ Vs. JEPI

canakat JPMorgan Equity Premium Income ETF (JEPI) and JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ) are two popular, high-yield monthly pay, diversified ETFs that have become very popular with income investors, as evidenced by their rapidly rising assets under management since launching just a few years ago: Data by YCharts In this article, we will…

Read More

Oracle: Palantir Partnership Is Big (NYSE:ORCL)

JasonDoiy/iStock Unreleased via Getty Images Investment Thesis As Oracle (NYSE:ORCL) continues to build out its position as one of the leaders in the AI database market, particularly in advanced database structures built for vector databases that store mountains of data for Large Language Models (LLMs), I believe that the company’s strong positioning in the generative…

Read More

SoFi: Disconnect With Big 2026 Targets (NASDAQ:SOFI)

Devrimb/iStock via Getty Images No matter the positive growth story from SoFi Technologies (NASDAQ:SOFI), the stock just limps along. The market is fixated with GAAP profits, yet the company is already highly profitable, warranting a higher stock price. My investment thesis is ultra Bullish on the stock based on the big 2026 financial targets and…

Read More

QQQ: The Big Tech Is Fundamentally Vulnerable (NASDAQ:QQQ)

flavijus/iStock Editorial via Getty Images The Big Tech story Before discussing the reasons why the Big Tech could be fundamentally vulnerable, it’s important to understand the Big Tech story. First of all, the Big Tech companies are the tech giants on forefront of innovation: Microsoft (MSFT), Apple (AAPL), Nvidia (NVDA), Amazon (AMZN), Meta (META) and…

Read More

Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration (NASDAQ:EVAX)

phuttaphat tipsana/iStock via Getty Images Thesis overview Evaxion (EVAX) aspires to use artificial intelligence (AI) to design vaccines for cancer immunotherapy, as well as for infectious diseases. EVAX claims being more advanced than competition because it has been constantly developing and improving its models for 15 years. Additionally, EVAX has in-house capability to validate novel…

Read More

Coupang Q423: Topline Growth, Intensifying Competition, Big Question On Recent Acquisition

Sundry Photography Recap In our last article on Coupang (NYSE:CPNG), we highlighted Coupang’s strong position in logistics as a key factor in driving its market share growth. Additionally, we observed robust growth in Taiwan, surpassing the growth seen in South Korea post-Rocket launch. Yet, we believe that Coupang’s stock was trading within its fair value…

Read More

Sanofi: My Top Pick In Big Pharma (NASDAQ:SNY)

AndreyPopov The large-cap pharmaceutical group has lagged the stock market badly over the past year, relative to the S&P 500 jump of +25% or high-flying NASDAQ 100 index spike of +40%. So, I consider this sector a good hunting ground for bargains. Since late summer, I have written bullish views on Pfizer (PFE) here and…

Read More

Big Yield, Big EM Alpha With DGS ETF

2d illustrations and photos Emerging Markets have become an after-thought for many investors today. With beyond a decade of severe underperformance to both large and small US stocks, the EM Index is rarely discussed among even macro investors. Consider that just in the last year, the broad EM ETF is up less than 10%, dividends…

Read More

Live Off Dividends With 2 Big Fat Yields

cokada Co-authored by Treading Softly. There’s a growing trend toward wanting to live more simply, especially among the middle-aged generation that is currently steeped in the workforce and trying to figure out retirement, families, and income. In prior generations, people flocked away from farmland in the rural communities to cities, which helped spawn innovation as…

Read More

The Boeing Crisis Benefits Airbus Big Time (NYSE:BA)

Aeon Aviation Photography/iStock Editorial via Getty Images As Boeing (NYSE:BA) is struggling to get its quality and manufacturing system in order while demand for commercial airplanes has increased significantly, it is clear that Airbus (OTCPK:EADSF) is the clear winner in the duopoly. That does not need much explanation. However, how big the benefit is for…

Read More

Canada’s Big Banks: More Beats Than Misses

Marc Dufresne Canada’s big banks reported quarterly results that mostly beat expectations. Mario Mendonca, Managing Director with TD Cowen, speaks with MoneyTalk’s Kim Parlee about the results and the outlook for the lenders going forward. Transcript Kim Parlee – Canada’s big banks have reported their quarterly results with most beating expectations. Here to break down…

Read More

The Fed Is At Risk Of Making A Big Mistake

Chip Somodevilla On the first day of Powell’s testimony, not much happened, and he failed to take control. There was very little that was new. This comes despite continued signs of inflation reaccelerating and robust economic data. If the Fed is correct in its assessment that inflation will return to target, the unemployment rate will…

Read More

Taboola: The Big Rebound Is Coming (NASDAQ:TBLA)

golibo In my previous coverage of the leading digital advertising company, Taboola (NASDAQ:TBLA), in June 2023 last year, I shared my buy thesis on how TBLA’s fundamentals and market leadership could pave the way to share price appreciation. Today, my call is proven to be right. TBLA is now trading at $4.36, an almost 50%…

Read More

DraftKings (DKNG) Stock: Time For A Big Bet

Justin Sullivan/Getty Images News Introduction In the rapidly evolving world of online gambling, DraftKings (NASDAQ:DKNG) stands out as one of the most exciting companies. As we dive into the company that is DraftKings, you will find a company that’s rapidly becoming one of the most recognizable names in online gambling with its bold strategies and…

Read More

Eli Lilly: Overvaluation Is A Big Red Flag (NYSE:LLY)

jetcityimage/iStock Editorial via Getty Images Investment thesis Eli Lilly’s (NYSE:LLY) stock is on fire after the massive success of its new drugs aimed at treating diabetes and obesity. The company has a stellar track record of success and will likely continue delivering strong results over the long term. However, my valuation analysis suggests that the…

Read More